Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience-Reference-Cited by-同舟云学术

Letermovir for primary and secondary cytomegalovirus prevention in allogeneic hematopoietic cell transplant recipients: Real‐world experience

Published:2019-10-21 Issue:6 Volume:21 Page:
ISSN:1398-2273
Container-title:Transplant Infectious Disease
language:en
Short-container-title:Transpl Infect Dis

Author:

Lin Andrew¹^ORCID,Maloy Molly²,Su Yiqi³,Bhatt Valkal¹,DeRespiris Lauren¹,Griffin Meagan¹,Lau Carmen¹,Proli Anthony¹,Barker Juliet²⁴,Shaffer Brian²⁴,Giralt Sergio A.²⁴,Jakubowski Ann A.²⁴,Papadopoulos Esperanza B.²⁴,Papanicolaou Genovefa A.³⁴,Seo Susan K.³⁴,Perales Miguel‐Angel²⁴

Affiliation:

1. Department of Pharmacy Memorial Sloan Kettering Cancer Center New York NY USA

2. Adult Bone Marrow Transplant Service Department of Medicine Memorial Sloan Kettering Cancer Center New York NY USA

3. Infectious Disease Service Department of Medicine Memorial Sloan Kettering Cancer Center New York NY USA

4. Department of Medicine Weill Cornell Medical College New York NY USA

Funder

National University Cancer Institute, Singapore

Publisher

Wiley

Subject

Infectious Diseases,Transplantation

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/tid.13187

Reference14 articles.

1. Donor Cytomegalovirus Status Influences the Outcome of Allogeneic Stem Cell Transplant: A Study by the European Group for Blood and Marrow Transplantation

2. Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis

3. How we treat cytomegalovirus in hematopoietic cell transplant recipients

4. Early Treatment with Ganciclovir to Prevent Cytomegalovirus Disease after Allogeneic Bone Marrow Transplantation

5. Cytomegalovirus viral load and mortality after haemopoietic stem cell transplantation in the era of pre-emptive therapy: a retrospective cohort study

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS.;Mediterranean Journal of Hematology and Infectious Diseases;2024-08-31

2. Antiviral Agents for Preventing Cytomegalovirus Disease in Recipients of Hematopoietic Cell Transplantation;Viruses;2024-08-08

3. Impact of Primary Letermovir Prophylaxis Versus Preemptive Antiviral Therapy for Cytomegalovirus on Economic and Clinical Outcomes after Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2024-08

4. Clinical Pharmacokinetics and Pharmacodynamics of Letermovir in Allogenic Hematopoietic Cell Transplantation;Clinical Pharmacokinetics;2024-07

5. Letermovir as secondary prophylaxis of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: A single center experience;European Journal of Haematology;2024-06-21